<?xml version="1.0" encoding="UTF-8"?>
<document id="29061647">
	<sentence id="s1" text="Pyridoxine-dependent epilepsy (cellular aldehyde metabolic process) is a rare disease characterized by mutations in the lysine degradation gene li>ALDH7A1</i> leading to recurrent neonatal seizures, which are uniquely alleviated by high doses of pyridoxine or pyridoxal 5'-phosphate (vitamin B6 vitamers).">
		<entity id="s1.e1" charOffset="21-29"
			type="HP" text="epilepsy" ontology_id="HP_0001250"/>
		<entity id="s1.e2" charOffset="31-66"
			type="GO" text="cellular aldehyde metabolic process" ontology_id="GO_0006081"/>
		<entity id="s1.e3" charOffset="189-197"
			type="HP" text="seizures" ontology_id="HP_0001250"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="true"/>
		<pair id="s1.p2" e1="s1.e2"
		    e2="s1.e3" pgr="true"/>
	</sentence>
	<sentence id="s2" text="Over 60 years after the initial description of cellular aldehyde metabolic process, we report the first animal model for this disease: an cellular aldehyde metabolic process-null zebrafish (li>Danio rerio</i>) displaying deficient lysine metabolism and spontaneous and recurrent seizures in the larval stage (10 days postfertilization).">
		<entity id="s2.e1" charOffset="47-82"
			type="GO" text="cellular aldehyde metabolic process" ontology_id="GO_0006081"/>
		<entity id="s2.e2" charOffset="138-173"
			type="GO" text="cellular aldehyde metabolic process" ontology_id="GO_0006081"/>
		<entity id="s2.e3" charOffset="251-259"
			type="HP" text="seizures" ontology_id="HP_0001250"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e3" pgr="true"/>
		<pair id="s2.p2" e1="s2.e2"
		    e2="s2.e3" pgr="true"/>
	</sentence>
	<sentence id="s3" text="Remarkably, as is the case in human cellular aldehyde metabolic process, the seizures show an almost immediate sensitivity to pyridoxine and pyridoxal 5'-phosphate, with a resulting extension of the life span.">
		<entity id="s3.e1" charOffset="36-71"
			type="GO" text="cellular aldehyde metabolic process" ontology_id="GO_0006081"/>
		<entity id="s3.e2" charOffset="77-85"
			type="HP" text="seizures" ontology_id="HP_0001250"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="true"/>
	</sentence>
	<sentence id="s4" text="Impaired lysine degradation with accumulation of cellular aldehyde metabolic process biomarkers, B6 deficiency, and low Î³-aminobutyric acid levels were observed in the li>cellular aldehyde metabolic process</i><sup>-/-</sup> larvae, which may play a significant role in the seizure phenotype and PDE pathogenesis.">
		<entity id="s4.e1" charOffset="49-84"
			type="GO" text="cellular aldehyde metabolic process" ontology_id="GO_0006081"/>
		<entity id="s4.e2" charOffset="171-206"
			type="GO" text="cellular aldehyde metabolic process" ontology_id="GO_0006081"/>
		<entity id="s4.e3" charOffset="246-253"
			type="HP" text="seizure" ontology_id="HP_0001250"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e3" pgr="true"/>
		<pair id="s4.p2" e1="s4.e2"
		    e2="s4.e3" pgr="true"/>
	</sentence>
	<sentence id="s5" text="This novel model provides valuable insights into cellular aldehyde metabolic process pathophysiology; further research may offer new opportunities for drug discovery to control seizure activity and improve neurodevelopmental outcomes for PDE">
		<entity id="s5.e1" charOffset="49-84"
			type="GO" text="cellular aldehyde metabolic process" ontology_id="GO_0006081"/>
		<entity id="s5.e2" charOffset="177-184"
			type="HP" text="seizure" ontology_id="HP_0001250"/>
		<pair id="s5.p1" e1="s5.e1"
		    e2="s5.e2" pgr="true"/>
	</sentence>
</document>
